Rankings / Toxins

BPA / BPS / BPF (bisphenols)

Toxins · Endocrine disruptor

Moderate exposure concern

endocrine-disruptor
4.7 / 10
MODERATE
Mag 5 Ev 6 Prev 3

Bottom line

Read Off Label rates BPA / BPS / BPF (bisphenols) a MODERATE exposure concern (4.7/10) based on moderate evidence of med harm magnitude and low-moderate chronic exposure prevalence.

EFSA 2023 TDI reduction of 20,000-fold is one of the most dramatic regulatory changes in chemical risk assessment.

This entry describes an exposure rather than an added intervention.

What the evidence says

EFSA 2023 TDI reduction of 20,000-fold is one of the most dramatic regulatory changes in chemical risk assessment. FDA largely disagrees with EFSA's assessment. BPS and BPF replacements show similar endocrine activity in vitro; BPA-free labeling does not exclude those compounds. Thermal receipts deliver detectable BPA through skin.

Mechanism

Bisphenol A (polycarbonate plastics, epoxy can linings, thermal paper receipts); weak estrogen receptor agonist; 'BPA-free' often means BPS/BPF — structurally similar, likely similar concerns ('regrettable substitution')

Reported exposure / mitigation context

Exposure-reduction contexts include glass or stainless containers, some BPA-free cans, avoiding heat exposure of plastics, and reduced thermal-receipt handling

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

How harmful is BPA / BPS / BPF (bisphenols)?
BPA / BPS / BPF (bisphenols) is rated MODERATE exposure concern (4.7/10) on the Read Off Label scale, derived from moderate evidence of med harm magnitude and low-moderate chronic exposure prevalence.
How does BPA / BPS / BPF (bisphenols) cause harm?
Bisphenol A (polycarbonate plastics, epoxy can linings, thermal paper receipts); weak estrogen receptor agonist; 'BPA-free' often means BPS/BPF — structurally similar, likely similar concerns ('regrettable substitution')
What exposure context is reported for BPA / BPS / BPF (bisphenols)?
EFSA 2023 TDI reduction of 20,000-fold is one of the most dramatic regulatory changes in chemical risk assessment.

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.